Major scientific advances are producing novel treatments for everything from cancer to hemophilia, and Reuters is providing unparalleled coverage of the resulting upheaval to global healthcare. New breakthroughs have emboldened Big Pharma to demand previously unimaginable prices and to recruit patient advocates to plead their case to regulators and insurers like never before. From the United States and Canada to Europe and Japan, governments are struggling to keep up with budget-busting medicines, and seek new strategies to contain those costs. Reuters is delivering exclusive news and insight on this new era of medicine and what it means for patients, businesses and investors.
The business of Big Pharma
22 May 2019, 12:00 am. 1 minute
Article Tags
Type: The Big Picture
Regions: Americas
More of Reuters Best
Reuters exclusively reports Indian sugar mills to close early as rain hits cane supply; sugar futures jump; shares fall
January 29, 2023
Reuters reveals that India may peg gross borrowing under 16 trillion rupees in 2023/24
January 27, 2023